you are here:

Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals

BSE Live

Jun 21, 16:00
1995.00 45.50 (2.33%)
Volume
AVERAGE VOLUME
5-Day
6,163
10-Day
6,151
30-Day
5,732
6,894
  • Prev. Close

    1949.50

  • Open Price

    1905.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jun 21, 15:55
1992.90 45.00 (2.31%)
Volume
AVERAGE VOLUME
5-Day
98,417
10-Day
93,057
30-Day
111,473
49,166
  • Prev. Close

    1947.90

  • Open Price

    1941.00

  • Bid Price (Qty.)

    1992.90 (125)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Ajanta Pharma

  • Apr 30, 2021 16:09 Source: BSE

    Ajanta Pharma - Outcome Of The Board Meeting - Approve And Take On Record The Audited (Consolidated & Standalone) Financial Results Of The Company For The Quarter And Year Ended 31St March 2021

    Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: 1. Press Release; 2. Audited Consolidated Financial Results for the quarter and year ended 31st March 2021 along with Auditors' report with unmodified opinion; 3. Audited Standalone Financial Results for the quarter and year ended 31st March 2021 along with Auditors' report with unmodified opinion; 4. Investor's presentation. Separate disclosure under Regulation 30 is being filed shortly. We shall inform in due course, date of the 42nd Annual General Meeting to be held for the year ended 31st March 2021. Meeting of the Board of Directors commenced at 2.00 p.m. and concluded at 4.00 p.m. Kindly take the above on your records.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Apr 30, 2021
Remark : Audited Results